US Company to Begin Second Phase of Human Trials in South Africa for COVID-19 Vaccine  | Voice of America

A U.S. based vaccine development company is set to begin the second phase of human testing for its COVID-19 vaccine in South Africa, which is in the midst of a surge in coronavirus cases.  

Novavax said in a statement that the clinical trials will include 2,665 healthy adults in South Africa. 

The trials will also compare the vaccine’s effect on 240 medically stable adults with HIV whose immune responses may differ from individuals without HIV. 

Preliminary findings from the first trial showed people receiving the two doses generated neutralizing…

Source link

About Author: ACM
This information is 3rd party content that is added to ACM strictly for non-commercial informational purposes. Information is the Key to Set the Black Mind Free